Market Ticker

Translate

Monday, June 21, 2010

Cadila Healthcare receives phase-I clinical trial permission from DCGI

Cadila Healthcare has received phase-I clinical trial permission from the DCGI for ZYOG1, a novel GLP-1 agonist, designed and developed at the company's research centre using a unique platform technology. ZYOG1 is a novel, oral anti-diabetic molecule.

No comments:

Economic Event Calendar

GMT+5:30 Event Vol. Actual Consensus Previous
Thursday, Jul 17
11:30 Employment Change (3M) 3 134K 89K
11:30 Average Earnings Excluding Bonus (3Mo/Yr) 2 5.0% 4.9% 5.2%
11:30 Imports (MoM) 1 18,350M 19,448M Revised from 19,469M
11:30 Exports (MoM) 1 24,140M 23,456M Revised from 23,300M
11:30 Trade Balance 1 5,790M 4,008M Revised from 3,831M
18:00 Retail Sales Control Group 3 0.4%
18:00 Retail Sales (YoY) 1 3.3%
18:00 Retail Sales ex Autos (MoM) 2 0.3% -0.3%
18:00 Retail Sales (MoM) 3 0.1% -0.9%
18:00 Initial Jobless Claims 2 235K 227K
Economic Calendar >> Add to your site

Best Mutual Funds

Recent Posts

Search This Blog

IPO's Calendar

Market Screener

NSE BSE Tiker

Custom Pivot Calculator

Popular Posts

Market & MF Screener